Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin

BACKGROUND: Simeprevir with peginterferon and ribavirin has been used for the treatment of chronic hepatitis caused by genotype 1 hepatitis C virus (HCV). We explored the predictive factors for sustained virological response (SVR) and viral relapse using datasets from four Japanese phase 3 studies (...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hepatol Int
Auteurs principaux: Nakayama, Masahiko, Kobayashi, Hisanori, Fukushima, Koji, Ishido, Miwako, Komada, Yuji, Yoshizawa, Kazutake
Format: Artigo
Langue:Inglês
Publié: Springer India 2015
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4722076/
https://ncbi.nlm.nih.gov/pubmed/26264253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-015-9654-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires